Jesús Moreno Sierra

Prognostic Significance of Circulating Tumor Cell Count in Patients With Metastatic Hormone-sensitive Prostate Cancer

Luis Resel Folkersma, Luís Manso, I. Galante Romo et al. · Urology · 2012 · 89 citations

Prognostic Biomarkers, Urology, Genitourinary Cancer +5

Long-Term Outcomes after Robotic Sacrocolpopexy in Pelvic Organ Prolapse: Prospective Analysis

Jesús Moreno Sierra, Elena Ortiz Oshiro, Cristina Fernández et al. · Urologia Internationalis · 2011 · 53 citations

Bladder Cancer in Spain 2011: Population Based Study

B. Miñana, J.M. Cózar, Joan Palou et al. · The Journal of Urology · 2013 · 52 citations

Bladder Carcinoma Data with Clinical Risk Factors and Molecular Markers: A Cluster Analysis

E. Redondo-González, Leandro Nunes de Castro, Jesús Moreno Sierra et al. · BioMed Research International · 2015 · 46 citations · Full text

Surgical Oncology, Molecular Markers, Pathology +18

Uncontrolled donation after circulatory death: A cohort study of data from a long-standing deceased-donor kidney transplantation program

Ana Sánchez‐Fructuoso, Isabel Pérez-Flores, Francisco del Río et al. · American Journal of Transplantation · 2018 · 41 citations · Full text